Eagle Health Investments LP
Sector Allocation
- Healthcare97.5%$588.5M
- Technology2.5%$14.8M
AUM History
13fpro.ai/research/fund/eagle-health-investments-lp-1842545
Conviction and streaks
Concentrating · top 10 = 66.1%From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.
Largest positions — Q2 2026
ARGX
$70.9MICLR
$53.5MGH
$45.1MINSM
$41.0MBMRN
$35.7MILMN
$33.0MSRRK
$30.5MPTGX
$30.4MRARE
$29.5MCMPS
$29.2MASND
$28.3MRVMD
$22.5MFTRE
$20.6MKYMR
$19.1MAXSM
$15.9MBSX
$15.8MALKS
$15.6MIONS
$15.4MTEM
$14.8MDNTH
$12.8M
Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.
13fpro.ai/research/fund/eagle-health-investments-lp-1842545
Eagle Health Investments LP 13F holdings — Q2 2026
$603.3M portfolio (+5.5% QoQ) · 27 holdings · Q2 2026 13F · top 10 are 66% of the stock portfolio
$70.9M
11.8% of stocks
+0.1%This quarter+0.4%Since filed10+ qtrsHeld$53.5M
8.9% of stocks
-14%This quarter+10.7%Since filed10+ qtrsHeld$45.1M
7.5% of stocks
-3%This quarter+3.6%Since filed5 qtrsHeld$41.0M
6.8% of stocks
+71%This quarter-30.7%Since filed9 qtrsHeldAIQuality39.4#2,143Est. buyEstimated buy price is Pro: unlock with a free trialAdded 2 qtrs in a row$35.7M
5.9% of stocks
+24%This quarter-19.1%Since filed9 qtrsHeldAIQuality58.0#1,047Est. buyEstimated buy price is Pro: unlock with a free trialAdded 2 qtrs in a row$33.0M
5.5% of stocks
No changeThis quarter+41.3%Since filed10+ qtrsHeld$30.5M
5.1% of stocks
+12%This quarter-19.6%Since filed5 qtrsHeldAIQualityAI quality score is Pro: unlock with a free trialEst. buyEstimated buy price is Pro: unlock with a free trialAdded 2 qtrs in a row$30.4M
5.0% of stocks
+38%This quarter-6.5%Since filed3 qtrsHeldAIQualityAI quality score is Pro: unlock with a free trialEst. buyEstimated buy price is Pro: unlock with a free trialAdded 3 qtrs in a row$29.5M
4.9% of stocks
No changeThis quarter-40.0%Since filed2 qtrsHeld$29.2M
4.8% of stocks
No changeThis quarter-16.2%Since filed4 qtrsHeld
All holdings — Eagle Health Investments LP (Q2 2026)
27 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.
| # | Company | Held | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11 | Ascendis Pharma A/S | Healthcare | $28.3M | 4.7% | 106K | +23% | 2 qtrsAdded 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 12 | Revolution Medicines, Inc. | Healthcare | $22.5M | 3.7% | 120K | +0.7% | 3 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 13 | Fortrea Holdings Inc. | Healthcare | $20.6M | 3.4% | 1.18M | -10% | 4 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 14 | Kymera Therapeutics, Inc. | Healthcare | $19.1M | 3.2% | 166K | +14% | 3 qtrsAdded 3 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 15 | Axsome Therapeutics, Inc. | Healthcare | $15.9M | 2.6% | 65K | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 16 | BOSTON SCIENTIFIC CORP | Healthcare | $15.8M | 2.6% | 369K | +26% | 2 qtrsAdded 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 17 | Alkermes plc. | Healthcare | $15.6M | 2.6% | 297K | +25% | 4 qtrsAdded 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 18 | IONIS PHARMACEUTICALS INC | Healthcare | $15.4M | 2.6% | 195K | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 19 | Tempus AI, Inc. | Technology | $14.8M | 2.5% | 256K | — | 2 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 20 | Dianthus Therapeutics, Inc. /DE/ | Healthcare | $12.8M | 2.1% | 131K | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 21 | Atai Beckley N.V. | Healthcare | $9.0M | 1.5% | 1.71M | — | 3 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 22 | Avalo Therapeutics, Inc. | Healthcare | $4.3M | 0.7% | 235K | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 23 | Natera, Inc. | Healthcare | $4.3M | 0.7% | 16K | -87% | 10+ qtrsTrimmed 9 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 24 | ELI LILLY & Co | Healthcare | $2.4M | 0.4% | 1,994 | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 25 | INTUITIVE SURGICAL INC | Healthcare | $1.7M | 0.3% | 4,390 | — | 10+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 26 | $IMCR | Immunocore Holdings plc | Healthcare | $1.5M | 0.2% | 46K | — | |||
| 27 | $FRNM | Freenome, Inc. | Healthcare | $410K | 0.1% | 38K | — |
What changed in Q2 2026
Against the previous quarter's 13F: 5 new, 10 added to, 4 trimmed, 6 sold out. Share-count changes; largest moves by dollar size first.
New positions (5)
Added to (10)
now $41.0M · held 9 qtrs, 2 adds in a row
now $30.4M · held 3 qtrs, 3 adds in a row
now $35.7M · held 9 qtrs, 2 adds in a row
now $28.3M · held 2 qtrs, 2 adds in a row
now $30.5M · held 5 qtrs, 2 adds in a row
now $15.8M · held 2 qtrs, 2 adds in a row
+4 more in the Excel export
Trimmed (4)
Holdings by quarter
Every 13F Eagle Health Investments LP has filed, 22 earlier quarters. Pick one to see what it held then.
Is it too late to follow Eagle Health Investments?
Q2 2026 13F filed with the SEC on Aug 10, 2026. Prices are closing prices as of Oct 26, 2026.
Average quality of Eagle Health Investments's top 20 holdings: 40/100 (our AI quality score, weighted by position size; 14 of the 20 are scored)
Top 10 since filing
-5.7%
Value-weighted move of the 10 largest stock positions
Turnover
19%
Last quarter; 67% over the last 4
Top 10 weight
66%
Share of the stock portfolio in its 10 largest positions
Held 4+ quarters
63%
Share of portfolio value in positions held a year or more
Highest-quality names it owns(among its 100 largest positions)
The 8 highest-scoring companies in this portfolio are a Pro feature.
How these are measured
- Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
- Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
- Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q1 2024 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
- Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
- Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.
Portfolio Overview
Eagle Health Investments LP disclosed 27 positions worth $603.3M in its Form 13F-HR for Q2 2026, led by $ARGX (ARGENX SE) at 11.8% of the equity portfolio, followed by $ICLR and $GH. During the quarter the fund opened 5 new positions and exited 6 — including a new stake in $AXSM. The portfolio is most concentrated in Healthcare (97.5% of disclosed assets). All figures are sourced directly from Eagle Health Investments LP’s Form 13F-HR filing with the SEC under CIK 1842545.
Funds like this
managers whose biggest positions overlap Eagle Health Investments'sBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
AI-Powered Hedge Fund Analysis: Eagle Health Investments LP
13F Pro is an AI hedge fund tracker and stock research platform. For Eagle Health Investments LP (SEC CIK: 1842545), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Eagle Health Investments LP's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.